Similar content being viewed by others
This article is cited by
-
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
Nature Reviews Clinical Oncology (2024)
-
Control of cell state transitions
Nature (2022)
-
Clinical cancer genomic profiling
Nature Reviews Genetics (2021)
-
Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma
Oncogene (2021)
-
Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy
Molecular Biomedicine (2020)